Sinobiomed Inc. (SOBM.OB): Chinese Wonder Drug-Maker?
Source: http://Blog.QualityStocks.netPosted on Friday, September 5th, 2008 | In Small & Micro Cap
Sinobiomed (SOBM) is a Chinese developer of genetically engineered recombinant protein drugs and vaccines. The company’s drugs treat diseases and ailments such as malaria, hepatitis, surgical bleeding, cancer, rheumatoid arthritis, diabetic ulcers and burns, and blood cell regeneration. Sinobiomed currently has 10 products: three on the market, four in clinical trials and three in research and development.
Sinobiomed, based in the bustling metropolis of Shanghai, could be on the forefront of the burgeoning Chinese biotechnology industry. China’s biotech industry is expected to continue its rapid expansion of 20 percent to 30 percent annually to $8.5 billion by 2010 helped by government contributions of $600 million annually. The Chinese pharmaceutical industry is expected to be the world’s 5th largest market by 2010.
Sinobiomed is considered a market leader in the area of recombinant protein drugs and recently acquired a distributor to facilitate a more expeditious sale of some its drugs. The company has one of China’s largest capacities for the manufacturing of recombinant bioproducts at an extremely low cost and its international alliances give the firm global advantages.
Sinobiomed also has a cosmetics and skin care business that is expected to generate sales of $3 million in the next year with profit margins of over 70 percent. The company is in talks with home shopping TV channels in China, India and other emerging markets to feature its skin care products.
The company said in August it received a $500,000 cash injection from Asian investment fund Accelera Ventures. Sinobiomed had total expenses of $1.8 million for the first three months of this year. Shares closed at 43 cents on Friday and have traded between 21 cents and $3.04 in the past 52 weeks.
Let us hear your thoughts below:
Last 5 posts by QualityStocks
- Satcon Technology Corp. (SATC) Lands Major Samsung Contract - November 19th, 2008
- EV Transportation, Inc.’s (EVTP.OB) Business Strategies - November 19th, 2008
- Stratos Renewables Corp. (SRNW.OB) Explores Potential with Clean Fuels - November 19th, 2008
- ClickSoftware Technologies Ltd. (CKSW) and Siemens Energy Combine Forces to Boost Productivity - November 19th, 2008
- Vortex Resources Corp. (VTEX.OB) Announces Successful Drilling and Engagement of Barnett-Shale Expert - November 19th, 2008
Accelera Ventures, Biotechnology, biotechnology industry, cancer, cents, China, hepatitis, India, Malaria, Pharmaceutical Industry, Rheumatoid Arthritis, shanghai, Sinobiomed Inc., skin care products, Small & Micro Cap, USD, Vaccines
 About QualityStocks (http://QualityStocks.net)
Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. We believe strong management and vision for the future are crucial for any company to be successful. Timing is everything and we help investors succeed by providing an objective, broad-based view of the SmallCap markets on a daily basis. Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.